Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.

Authors:
Sareh Shahmohammadi Rozita Doosti Abootorab Shahmohammadi Seyed Ehsan Mohammadianinejad Mohammad Ali Sahraian Amir Reza Azimi Mohammad Hossein Harirchian Nasrin Asgari Abdorreza Naser Moghadasi

Mult Scler Relat Disord 2019 Jan 16;27:350-363. Epub 2018 Nov 16.

MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

Introduction: Neuromyelitis Optica (NMO) is an autoimmune inflammatory demyelinating disease of the central nervous system (CNS) which predominantly involves optic nerves and spinal cord. Since the introduction of Neuromyelitis Optica Spectrum Disorders (NMOSD) as a separate entity, there have been many reports on its association with other disorders including systemic and organ-specific autoimmune diseases. Here, we reviewed other immune-mediated diseases associated with NMOSD and tried to categorize them.

Methods: The present review was conducted using the PUBMED database based on papers from 1976 (i.e., since the first NMO comorbidity with SLE was reported) to 2017. We included all articles published in English. The keywords utilized included Neuromyelitis optica, Neuromyelitis Optica Spectrum Disorders, Devic's disease, in combination with comorbidity or comorbidities.

Results: Diseases with immune-based pathogenesis are the most frequently reported co-morbidities associated with NMOSD, most of which are antibody-mediated diseases. According to literature, Sjogren's Syndrome (SS) and Systemic Lupus Erythematosus (SLE) are the most frequently reported diseases associated with NMOSD among systemic autoimmune diseases. Further, myasthenia gravis in neurological and autoimmune thyroid diseases in non-neurological organ-specific autoimmune diseases are the most reported comorbidities associated with NMOSD in the literature.

Conclusions: NMOSD may be associated with a variety of different types of autoimmune diseases. Therefore, systemic or laboratory signs which are not typical for NMOSD should be properly investigated to exclude other associated comorbidities. These comorbidities may affect the treatment strategy and may improve the patients' care and management.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.11.008DOI Listing
January 2019

Publication Analysis

Top Keywords

neuromyelitis optica
20
autoimmune diseases
20
associated nmosd
16
spectrum disorders
12
optica spectrum
12
diseases associated
12
diseases
9
introduction neuromyelitis
8
frequently reported
8
organ-specific autoimmune
8
associated
7
autoimmune
7
nmosd
7
optica
5
neuromyelitis
5
reported co-morbidities
4
immune-based pathogenesis
4
diseases immune-based
4
co-morbidities associated
4
pathogenesis frequently
4

Altmetric Statistics


Show full details
3 Total Shares
1 Facebook Pages
2 Tweets
3 Citations

Similar Publications

Autologous hematopoietic stem cell transplantation in a pediatric patient with aquaporin-4 neuromyelitis optica spectrum disorder.

Authors:
Tuba Rashid Khan Vincent Zimmern Victor Aquino Cynthia Wang

Mult Scler Relat Disord 2021 Feb 25;50:102852. Epub 2021 Feb 25.

Department of Pediatrics, 5323 Harry Hines Blvd. Dallas, Texas 75390, United States; Department of Neurology, 5323 Harry Hines Blvd. Dallas, Texas 75390, United States.

We report on a child with an early and severe manifestation of an Aquaporin-4 (AQP-4) positive Neuromyelitis Optica Spectrum Disorder (NMOSD) who had a refractory disease course despite aggressive immunotherapy and underwent autologous hematopoietic stem cell transplant (AHSCT). Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis.

Authors:
Samar A Zailaie Jumana Jamal Siddiqui Rawan Mansour Al Saadi Dalia Mohammad Anbari Amani S Alomari Edward James Cupler

Immunol Invest 2021 Mar 4:1-16. Epub 2021 Mar 4.

Research Center Department, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia.

This systematic review and meta-analysis aimed to identify deferentially expressed serum miRNAs in multiple sclerosis patients and to evaluate their diagnostic value in multiple sclerosis diagnosis. Studies were identified on PubMed, Google scholar and Saudi digital library up to 30 September 2019. Articles that examined miRNA expression level in MS patients compared to healthy control group were included in the review and the data were extracted by three independent author. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Potential Role of CHI3L1+ Astrocytes in Progression in MS.

Authors:
Laura Cubas-Núñez Sara Gil-Perotín Jéssica Castillo-Villalba Verónica López Luis Solís Tarazona Raquel Gasqué-Rubio Sara Carratalá-Boscá Carmen Alcalá-Vicente Francisco Pérez-Miralles Hans Lassmann Bonaventura Casanova

Neurol Neuroimmunol Neuroinflamm 2021 May 3;8(3). Epub 2021 Mar 3.

From the Neuroimmunology Unit (L.C.-N., S.G.-P., J.C.-V., V.L., R.G., S.C., C.A., F.P.-M., B.C.), Polytechnic and University Hospital La Fe; Neurology Department (L.S.T.), University Hospital Dr Peset, Valencia, Spain; and Department of Neuroimmunology (H.L.), Center for Brain Research, Vienna, Austria.

Objective: Neurofilament light protein (NfL) and chitinase 3-like 1 (CHI3L1) are biomarkers for acute neuroaxonal damage and local inflammation, respectively. Thus, we set out to evaluate how these biomarkers were associated with clinical features of demyelinating diseases in parallel with the expression in brain autopsies from patients with similar disease stages, assuming their comparability.

Methods: NfL and CHI3L1 in CSF and serum CHI3L1 were assessed retrospectively in a cross-sectional cohort of controls (n = 17) and patients diagnosed with MS (n = 224), relapsing (n = 163) or progressive (n = 61); neuromyelitis optica (NMO, n = 7); and acute disseminated encephalomyelitis (ADEM, n = 15). Read More

View Article and Full-Text PDF
May 2021
Similar Publications

Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.

Authors:
Hesham Abboud John C Probasco Sarosh Irani Beau Ances David R Benavides Michael Bradshaw Paulo Pereira Christo Russell C Dale Mireya Fernandez-Fournier Eoin P Flanagan Avi Gadoth Pravin George Elena Grebenciucova Adham Jammoul Soon-Tae Lee Yuebing Li Marcelo Matiello Anne Marie Morse Alexander Rae-Grant Galeno Rojas Ian Rossman Sarah Schmitt Arun Venkatesan Steven Vernino Sean J Pittock Maarten J Titulaer

J Neurol Neurosurg Psychiatry 2021 Mar 1. Epub 2021 Mar 1.

Neurology, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.

The objective of this paper is to evaluate available evidence for each step in autoimmune encephalitis management and provide expert opinion when evidence is lacking. The paper approaches autoimmune encephalitis as a broad category rather than focusing on individual antibody syndromes. Core authors from the Autoimmune Encephalitis Alliance Clinicians Network reviewed literature and developed the first draft. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management.

Authors:
Hesham Abboud John Probasco Sarosh R Irani Beau Ances David R Benavides Michael Bradshaw Paulo Pereira Christo Russell C Dale Mireya Fernandez-Fournier Eoin P Flanagan Avi Gadoth Pravin George Elena Grebenciucova Adham Jammoul Soon-Tae Lee Yuebing Li Marcelo Matiello Anne Marie Morse Alexander Rae-Grant Galeno Rojas Ian Rossman Sarah Schmitt Arun Venkatesan Steven Vernino Sean J Pittock Maarten Titulaer

J Neurol Neurosurg Psychiatry 2021 Mar 1. Epub 2021 Mar 1.

Neurology, Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands.

The objective of this paper is to evaluate available evidence for each step in autoimmune encephalitis management and provide expert opinion when evidence is lacking. The paper approaches autoimmune encephalitis as a broad category rather than focusing on individual antibody syndromes. Core authors from the Autoimmune Encephalitis Alliance Clinicians Network reviewed literature and developed the first draft. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap